Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
Abstract
To determine the performance of Prostate Health Index (PHI) density (PHID) combined with MRI and prior negative biopsy (PNB) status for the diagnosis of clinically significant prostate cancer (PCa).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 09, 2018
- Source ID
- 10.1111/bju.14098
Entities
People
- Alan W. Partin
- Allen Young
- Arnav Srivastava
- Ashley E. Ross
- Christian P. Pavlovich
- H. Ballentine Carter
- Jeffrey J Tosoian
- Kamyar Ghabili
- Katarzyna J. Macura
- Lori J. Sokoll
- Sarah Collica
- Sasha C Druskin
Organizations
- Johns Hopkins University
- Prostate Cancer Foundation
- United States Department of Defense
- Yale School of Medicine